Vivo Capital, LLC Q3 2023 Filing
Filed November 8, 2023
Portfolio Value
$912.8T
Holdings
53
Report Date
Q3 2023
Filing Type
13F-HR
All Holdings (53 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —Genetron Holdings Ltd | 8,124,174 | $104.6T | 11.46% | |
| 2 | SLNOSoleno Therapeutics Inc | 3,203,093 | $94.5T | 10.36% | |
| 3 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $85.4T | 9.36% | |
| 4 | VRNAVerona Pharma PLC | 4,249,918 | $69.3T | 7.59% | |
| 5 | AVDLAvadel Pharmaceuticals PLC | 4,096,428 | $42.2T | 4.62% | |
| 6 | TARSTarsus Pharmaceuticals Inc | 2,262,200 | $40.2T | 4.40% | |
| 7 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2T | 4.18% | |
| 8 | GONGeron Corp | 16,524,634 | $35.0T | 3.84% | |
| 9 | TERNTerns Pharmaceuticals Inc | 6,657,992 | $33.5T | 3.67% | |
| 10 | GRCLGracell Biotechnologies Inc | 10,881,144 | $31.3T | 3.43% | |
| 11 | VRDNViridian Therapeutics Inc | 1,678,207 | $25.7T | 2.82% | |
| 12 | OLMAOlema Pharmaceuticals Inc | 1,873,704 | $23.1T | 2.54% | |
| 13 | COGTCogent Biosciences Inc | 2,244,941 | $21.9T | 2.40% | |
| 14 | ALXOALX Oncology Holdings Inc | 4,220,048 | $20.3T | 2.22% | |
| 15 | ACLXArcellx Inc. | 503,565 | $18.1T | 1.98% | |
| 16 | VTYXVentyx Biosciences Inc | 422,075 | $14.7T | 1.61% | |
| 17 | —Rayzebio Inc | 633,576 | $14.1T | 1.54% | |
| 18 | —Icosavax, Inc. | 1,704,568 | $13.2T | 1.45% | |
| 19 | CATBUSDAstria Therapeutics Inc | 1,681,199 | $12.5T | 1.37% | |
| 20 | VSTMVerastem Inc | 1,538,461 | $12.5T | 1.37% | |
| 21 | CMPSCompass Pathway PLC | 1,608,000 | $11.9T | 1.30% | |
| 22 | ZLABZai Lab Ltd ADR | 454,606 | $11.1T | 1.21% | |
| 23 | NVLSEURAlpine Immune Sciences Inc | 914,913 | $10.5T | 1.15% | |
| 24 | CRNXCrinetics Pharmaceuticals Inc | 350,000 | $10.4T | 1.14% | |
| 25 | DYNDyne Therapeutics Inc | 1,035,136 | $9.3T | 1.02% | |
| 26 | IOBTIO Biotech Inc | 6,173,439 | $8.7T | 0.95% | |
| 27 | APGEApogee Therapeutics Inc | 400,000 | $8.5T | 0.93% | |
| 28 | KALVKalVista Pharmaceuticals Inc. | 856,008 | $8.2T | 0.90% | |
| 29 | DCTHDelcath Systems, Inc. | 1,855,191 | $7.5T | 0.82% | |
| 30 | YB4PSavara Inc | 1,913,349 | $7.2T | 0.79% | |
| 31 | CMPXCompass Therapeutics Inc | 3,556,023 | $7.0T | 0.77% | |
| 32 | ALLKGUSDAllakos Inc | 2,988,000 | $6.8T | 0.74% | |
| 33 | WHWKAadi Bioscience Inc | 509,572 | $6.5T | 0.71% | |
| 34 | ACRSAclaris Therapeutics, Inc. | 898,631 | $6.2T | 0.67% | |
| 35 | TILInstil Bio Inc | 12,486,787 | $5.3T | 0.59% | |
| 36 | ORICOric Pharmaceuticals Inc | 777,944 | $4.7T | 0.52% | |
| 37 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $4.0T | 0.44% | |
| 38 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $3.7T | 0.40% | |
| 39 | —DBV Technologies SA | 2,708,875 | $3.7T | 0.40% | |
| 40 | SERASera Prognostics Inc | 1,856,011 | $3.5T | 0.38% | |
| 41 | UNCYUnicycive Therapeutics | 3,470,152 | $3.0T | 0.33% | |
| 42 | IOVAIovance Biotherapeutics Inc | 655,057 | $3.0T | 0.33% | |
| 43 | ALGSAligos Therapeutics Inc | 3,547,030 | $2.6T | 0.29% | |
| 44 | FULCFulcrum Therapeutics Inc | 520,000 | $2.3T | 0.25% | |
| 45 | CLNNEURClene Inc | 2,645,338 | $1.4T | 0.15% | |
| 46 | —Impel NeuroPharma Inc | 2,884,789 | $1.2T | 0.14% | |
| 47 | —Aslan Pharmaceuticals Ltd | 568,182 | $1.1T | 0.12% | |
| 48 | BCABBioAtla Inc | 534,181 | $908.1B | 0.10% | |
| 49 | CDXSCodexis, Inc | 388,144 | $733.6B | 0.08% | |
| 50 | RZLTRezolute Inc | 484,439 | $639.5B | 0.07% | |
| 51 | AMRSEURAmyris, Inc | 7,750,828 | $465.1B | 0.05% | |
| 52 | FIXXEURHomology Medicines, Inc. | 370,068 | $433.0B | 0.05% | |
| 53 | DTILPrecision Biosciences Inc | 140,255 | $47.9B | 0.01% |